$10.1 Billion is the total value of HHLR ADVISORS, LTD.'s 91 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CVAC | Exit | CUREVAC N V | $0 | – | -51,199 | -100.0% | -0.03% | – |
| CBMG | Exit | CELLULAR BIOMEDICINE GROUP I | $0 | – | -235,214 | -100.0% | -0.03% | – |
| ATNX | Exit | ATHENEX INC | $0 | – | -431,440 | -100.0% | -0.04% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -125,000 | -100.0% | -0.04% | – |
| FUTU | Exit | FUTU HLDGS LTDspon ads cl a | $0 | – | -150,000 | -100.0% | -0.06% | – |
| GTHX | Exit | G1 THERAPEUTICS INC | $0 | – | -474,716 | -100.0% | -0.07% | – |
| TXG | Exit | 10X GENOMICS INC | $0 | – | -75,000 | -100.0% | -0.08% | – |
| BLI | Exit | BERKELEY LTS INC | $0 | – | -200,000 | -100.0% | -0.14% | – |
| EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -178,600 | -100.0% | -0.19% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INC | $0 | – | -600,000 | -100.0% | -0.19% | – |
| Z | Exit | ZILLOW GROUP INCcl c cap stk | $0 | – | -302,336 | -100.0% | -0.31% | – |
| MELI | Exit | MERCADOLIBRE INC | $0 | – | -27,525 | -100.0% | -0.37% | – |
| YQ | Exit | 17 ED & TECHNOLOGY GROUP INCads | $0 | – | -4,643,391 | -100.0% | -0.47% | – |
| SE | Exit | SEA LTDsponsord ads | $0 | – | -337,622 | -100.0% | -0.53% | – |
| VIE | Exit | VIELA BIO INC | $0 | – | -2,382,414 | -100.0% | -0.68% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -182,283 | -100.0% | -0.77% | – |
| TAL | Exit | TAL EDUCATION GROUPsponsored ads | $0 | – | -4,055,722 | -100.0% | -2.31% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.